3 research outputs found

    Overriding adaptive resistance to sorafenib through combination therapy with Src homology 2 domain–containing phosphatase 2 blockade in hepatocellular carcinoma

    No full text
    Title on author’s file: Overriding adaptive resistance to sorafenib via combination therapy with SHP2 blockade in hepatocellular carcinoma202308 bckwAccepted ManuscriptRGCPublishe

    EPHB2 activates β-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma

    No full text
    202106 bcvcAuthor’s OriginalRGCRGC GRF 15103817, Theme-based Research Scheme project (T12-704/16-R )Publishe
    corecore